市場調查報告書
商品編碼
1159368
腎臟癌的全球市場(2022年~2028年)Kidney Cancer Market 2022-2028 |
全球腎臟癌的市場規模在預測期間內預計將以6.2%大幅年複合成長率成長。推動市場成長的主要因素有身體活動低,過度的抽煙·飲酒等。
本報告提供全球腎臟癌市場調查,提供市場概要,市場趨勢的分析,各癌症類型·癌症細胞·各診斷方法·不同治療·各地區的分析,競爭情形,再加上主要企業的簡介等全面性資訊。
Global Kidney Cancer Market Size, Share & Trends Analysis Report by Cancer Type (Renal Cell Carcinoma (RCC), Transitional Cell Cancer, Wilm's Tumor (Nephroblastoma), and Others (Sarcoma, Lymphoma)), by Cancer Cell (Clear Cell, Papillary, and Other) by Diagnosis (Biopsy, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), and Ultrasound) and by Therapy (Surgery, Immunotherapy, Chemotherapy, Radiation Therapy, and Cryotherapy) Forecast (2022-2028)
The global kidney cancer market is anticipated to grow at a substantial CAGR of 6.2% during the forecast period. As per the American Cancer Society, kidney cancer is among the 10 most common cancers in both men and women. Overall, the lifetime risk for developing kidney cancer in men is about 1 in 46 (2.02%). The lifetime risk for women is about 1 in 80 (1.03%). Reduced physical activity and excessive smoking and drinking are also a factor that is driving the kidney cancer market.
The global kidney cancer market is segmented based on the cancer type, cancer cell, diagnosis, and therapy. Based on the cancer type, the market is segmented into renal cell carcinoma (RCC), transitional cell cancer, Wilm's tumor (nephroblastoma), and others. Based on the cancer cell, the market is sub-segmented into a clear cell, papillary, and other. Based on the diagnosis, the market is sub-segmented into biopsy, computed tomography (CT) scan, magnetic resonance imaging (MRI), and ultrasound. Based on therapy, the market is sub-segmented into surgery, immunotherapy, chemotherapy, radiation therapy, and cryotherapy.
Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The market in the Asia-Pacific region is growing during the forecast period. The major countries contributing to the APAC region are China, Australia, Japan, and India. A large customer base, high consumption of Tabaco, and continuous increment in economy and healthcare facility are the major factor for the growth of the market in the region. The drugmaker launched SUTIB, the generic version of Sunitinib oral capsules to treat kidney cancer, in India. The drug is launched at an MRP that is approximately 96% lower than the MRP compared to the innovator brand, priced at Rs 7000 (50 mg), Rs 3600 (25 mg), and Rs 1840 (12.5 mg) per month. Sunitinib is also approved by the US Food and Drug Administration (US FDA).
The major companies serving the global kidney cancer market include AbbVie Inc., Bayer Pharma AG, Merck & Co., GlaxoSmithKline Plc, and Pfizer Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2021, MSN Labs launched Cabolong, a branded generic of Cabozantinib, for the treatment of renal cell carcinoma. Cabolong is available in 20mg, 40mg, and 60mg strengths at the pricing of below ₹10,000 for a monthly treatment regimen with the highest strength.
Research Methodology
The market study of the global pharmaceutical filtration market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: